A71 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ascendis Pharma A/S

Watchlist Manager

Watchlist

Price: 206 EUR 0.98% Market Closed

Market Cap: €11.8B

A	Ascendis Pharma A/S F:A71	DK
M	MCS Steel PCL SET:MCS	TH
B	Bold Eagle Acquisition Corp NASDAQ:BEAG	US

Profitability Summary

Ascendis Pharma A/S's profitability score is 68/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

91%

Strong 3Y Average Gross Margin

86%

Gross Margin is Increasing

80% > 91%

Healthy Operating Margin

25%

Negative 3Y Average Operating Margin

-91%

Operating Margin is Increasing

-484% > 25%

Exceptional Net Margin

71%

Negative 3Y Average Net Margin

-100%

Net Margin is Increasing

-511% > 71%

Exceptional Free Cash Flow Margin

32%

Negative 3Y Average Free Cash Flow Margin

-85%

Free Cash Flow Margin is Increasing

-461% > 32%

Exceptional ROE

119%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-60%

ROIC is Increasing

-205% > 216%

View All

Hide

Collapse

68 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.